Next Article in Journal
Cell-to-Cell Spread of Retroviruses
Next Article in Special Issue
Innate Antiviral Immune Responses to Hepatitis B Virus
Previous Article in Journal
T Cell Polarization at the Virological Synapse
Previous Article in Special Issue
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
Article Menu

Export Article

Open AccessReview
Viruses 2010, 2(6), 1279-1305;

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections

Rega Institute for Medical Research, K.U. Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
This paper is to be considered as a revised and updated version of the paper published by Férir et al.: Ferir, G.; Kaptein, S.; Neyts, J., De Clercq, E. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future. Rev. Med. Virol. 2008, 18, 19-34.
Author to whom correspondence should be addressed.
Received: 9 March 2010 / Revised: 18 May 2010 / Accepted: 25 May 2010 / Published: 31 May 2010
(This article belongs to the Special Issue Hepatitis Viruses)
Full-Text   |   PDF [709 KB, uploaded 12 May 2015]   |  


While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudine and tenofovir (disoproxil fumarate). In contrast to the treatment of HIV infections where the individual drugs are routinely used in combination, for the treatment of chronic HBV infection the individual drugs are generally used in monotherapy. In principle, combination drug therapy should allow reducing the likelihood of drug-resistant development. View Full-Text
Keywords: antiviral therapy; HBV therapy; nucleoside analogs; viral hepatitis antiviral therapy; HBV therapy; nucleoside analogs; viral hepatitis

Figure 1

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

De Clercq, E.; Férir, G.; Kaptein, S.; Neyts, J. Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections. Viruses 2010, 2, 1279-1305.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top